Proprotein convertase subtilisin/kexin type 9 inhibits interferon β expression through interacting with ATF-2-Reference-Cited by-同舟云学术

Proprotein convertase subtilisin/kexin type 9 inhibits interferon β expression through interacting with ATF-2

Published:2018-06-21 Issue:13 Volume:592 Page:2323-2333
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Li Zhubing¹,Liu Qiang²

Affiliation:

1. Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac); School of Public Health Vaccinology and Immunotherapeutics; University of Saskatchewan; Saskatoon Canada

2. Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac); School of Public Health Vaccinology and Immunotherapeutics; Department of Veterinary Microbiology; University of Saskatchewan; Saskatoon Canada

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/1873-3468.13152/fullpdf

Reference41 articles.

1. Current progress in host innate and adaptive immunity against hepatitis C virus infection;Shi;Hepatol Int,2017

2. Hepatitis C virus-induced autophagy and host innate immune response;Chan;Viruses,2017

3. Innate immunity and HCV;Heim;J Hepatol,2013

4. Innate immune responses to hepatitis C virus;Schoggins;Curr Top Microbiol Immunol,2013

5. Innate and adaptive immune responses in HCV infections;Heim;J Hepatol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside;Signal Transduction and Targeted Therapy;2024-01-08

2. Suppression of KLF5 basal expression in oral carcinoma-derived cells through three intact CREB1-binding sites in the silencer region;Journal of Oral Biosciences;2023-12

3. A bibliometric analysis of PCSK9 inhibitors from 2007 to 2022;Frontiers in Endocrinology;2023-11-29

4. Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses;Frontiers in Cardiovascular Medicine;2022-02-10

5. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection;Lipids in Health and Disease;2021-10-25